ArticleCell medicine2017

A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease.

Jeong Chan Ra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.